한국어
Quantus

TEN Holdings, Inc. Common Stock

XHLD · Nasdaq
$9.24+0.11%
2026-09-04 close

TEN Holdings, Inc. Common Stock last closed at $9.24 (+0.11%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
Market Leader RS 99 · top 1%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -9.89
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-9.89
Beneish M-Score

Statistical flag unavailable

Sloan accrual
-7.52%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

1/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score1/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -71%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Balance sheetDanger

자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-77.9%
Interest coverage
-13x
Return on equity (ROE)

Operating margin −5pp

Operating loss
Interest coverageBase -13x adverse case -13.8x
Return on equity (ROE)Base adverse case

Revenue −15%

Interest coverage risk
Interest coverageBase -13x adverse case -11x
Return on equity (ROE)Base adverse case

Interest rate +2pp

Interest coverage risk
Interest coverageBase -13x adverse case -7.4x
Return on equity (ROE)Base adverse case

Interest coverage limit

Already below the limit by 83.8pp

Interest coverage limit at an operating margin of 6%

Interest expense coverage threshold

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About TEN Holdings, Inc. Common Stock
What technical signals does TEN Holdings, Inc. Common Stock (XHLD) have?
TEN Holdings, Inc. Common Stock current technical signals: no active technical signal.
Is TEN Holdings, Inc. Common Stock a cup-and-handle pattern?
No. TEN Holdings, Inc. Common Stock has no valid cup-and-handle signal right now.
What are TEN Holdings, Inc. Common Stock's financials and valuation?
TEN Holdings, Inc. Common Stock's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy